Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy

Critical Reviews in Oncology/hematology
E DiamondDavid M Nanus

Abstract

Renal cell carcinoma (RCC) is a heterogeneous disease with regards to histology, progression, and response to treatment. Cytotoxic chemotherapy has been extensively studied in metastatic RCC (mRCC). Responses in most studies are modest and the mechanisms of resistance remain poorly understood. Targeted therapies have significantly improved outcomes in mRCC; however, most patients eventually relapse and die of their disease. Early clinical data suggest that combinations of chemotherapy and targeted agents are clinically active and are well tolerated. We reviewed the available literature for published clinical trials incorporating traditional chemotherapeutic agents in the treatment of mRCC. These papers were identified through a Medline search and were included if they employed at least one chemotherapeutic agent in the treatment of mRCC. The literature was also reviewed for information regarding mechanisms of chemotherapy resistance. The data regarding the use of cytotoxic chemotherapy in mRCC consist of small, non-randomized phase I and II studies. The major response proportions with single agent chemotherapies are low but combination regimens either with other cytotoxic agents, cytokines, or targeted agents have demonstrated ...Continue Reading

References

Jan 1, 1991·Cancer Investigation·A I EinzigP H Wiernik
Sep 1, 1990·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·C Cordon-CardoM R Melamed
May 4, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·E T WalpoleG Cavasotto
Jan 1, 1996·Cancer Chemotherapy and Pharmacology·P H De MulderJ Blatter
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M MiwaH Ishitsuka
Jan 27, 2000·The Journal of Urology·R J Motzer, P Russo
Jan 5, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Catharina WenzelGuenther G Steger
Feb 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C M GeorgeW M Stadler
May 3, 2003·Cancer Cell·Nicola J MabjeeshParaskevi Giannakakou
Jun 2, 2004·Nature Reviews. Cancer·Robert S Kerbel, Barton A Kamen
Jul 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Susan E BatesTito Fojo
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roisean E FergusonRosamonde E Banks
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David F McDermott
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Agustin A GarciaAmit M Oza
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
Oct 8, 2008·American Journal of Clinical Oncology·Lauren C HarshmanSandy Srinivas
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerRobert A Figlin
Sep 23, 2009·Cancer Chemotherapy and Pharmacology·Kaisa Leea SunelaPirkko-Liisa Kellokumpu-Lehtinen
Oct 20, 2009·The Journal of Urology·Jonathan L WrightDaniel W Lin
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins
Mar 13, 2010·The Journal of Pathology·Marcella M BaldewijnsAdriaan P de Bruïne
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierVesna Sneller
Oct 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Seiji NaitoHideyuki Akaza
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen L RicheyNizar M Tannir

❮ Previous
Next ❯

Citations

Jan 26, 2017·The New England Journal of Medicine·Toni K Choueiri, Robert J Motzer
Jan 13, 2018·Expert Opinion on Investigational Drugs·Mehmet Asim BilenGuru Sonpavde
Jan 16, 2019·Journal of Cellular Physiology·Bing ZhongRuipeng Jia
Jul 15, 2020·Pharmacology Research & Perspectives·Ashley M HopkinsMichael J Sorich
Feb 20, 2016·Oncology Letters·Kunihiko MiyazakiNobuyuki Hizawa
Jun 1, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John A ThompsonChristian K Kollmannsberger
Nov 11, 2019·Journal of Pharmaceutical and Biomedical Analysis·Malena ManziMaría Eugenia Monge
Jun 18, 2021·Frontiers in Oncology·Jing-Min ZhengYi-Qing Guo
Sep 28, 2018·Journal of Proteome Research·María Elena KnottMaría Eugenia Monge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.